Lifesaving treatment and prevention programs for tuberculosis, malaria, H.I.V. and other diseases cannot access funds to continue work.

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.

While some agree with Robert F. Kennedy Jr. that the agency needs reform, their ideas for fixing it are very different from his.